With its concentrated HIV epidemic, the Middle East and North Africa has the advantage of a relatively low HIV burden among the general population, as well as among children and adolescents.
The possibility of new PrEP drug raises questions about how to fix gaps in data on women. Medicare will cover CAR-T cell therapy with significant moves to broaden administration and eligible patients. Sarepta denies a serious patient response to its Duchenne’s therapy, but its stock plunges.
Compared with older and white participants, younger black, Latina, Asian, and other/mixed race transgender (trans) women reported earlier experiences of sexual debut, transfeminine identity disclosure to others, sexual debut as trans, transfeminine identity expression in public, and integration of hormone use.
Authors recommend a systematic implementation of peer educator as an implementation strategy to improve and optimize the utilization and acceptance of FSWs to female condoms.
Private sector providers may need more support and training to effectively distribute HIV self-testing kits to adolescents and young adults, according to research conducted in Kenya and presented to the 10th International AIDS Society Conference on HIV Science (IAS 2019) last week in Mexico City.
Upwards of 6,000 people from around the world attended the International AIDS Society’s Conference on HIV Science that took place in Mexico City this week.
HIV self-tests (home tests) frequently give false-negative results when used by people with diagnosed HIV who are taking antiretroviral therapy, with implications for the messaging around self-testing
A new phase III HIV vaccine trial will soon be underway for men who have sex with men and transgender people.
The roll-out of pre-exposure prophylaxis (PrEP) provides an opportunity to bring down the incidence of sexually transmitted infections (STIs), provided that PrEP and STI programmes are better co-ordinated and integrated
A Rainbow Community Kampuchea report on Wednesday noted that more than 80 percent of lesbians, bisexuals and transgenders in the Kingdom suffer emotional violence from their family members.
Dr Armstrong along with other physicians, scientists, government agencies, and companies are questioning whether the way they've always recruited for clinical trials still serves patients.
Impressive advances in some countries, troubling failures in others as available resources for HIV fall by nearly US$ 1 billion